Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Free Cash Flow (2016 - 2025)

Healthstream (HSTM) has disclosed Free Cash Flow for 16 consecutive years, with $16.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 212.62% to $16.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $62.8 million, a 103.25% increase, with the full-year FY2025 number at $62.8 million, up 103.25% from a year prior.
  • Free Cash Flow was $16.2 million for Q4 2025 at Healthstream, up from $14.6 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $31.2 million in Q4 2023 to a low of -$14.4 million in Q4 2024.
  • A 5-year average of $12.2 million and a median of $14.1 million in 2021 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: surged 574.35% in 2022, then plummeted 146.15% in 2024.
  • Healthstream's Free Cash Flow stood at $19.1 million in 2021, then grew by 29.64% to $24.8 million in 2022, then rose by 25.8% to $31.2 million in 2023, then crashed by 146.15% to -$14.4 million in 2024, then skyrocketed by 212.62% to $16.2 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Free Cash Flow are $16.2 million (Q4 2025), $14.6 million (Q3 2025), and $5.1 million (Q2 2025).